584 related articles for article (PubMed ID: 8804210)
1. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
Sanner T; Dybing E
Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
3. Risk biomarkers and current strategies for cancer chemoprevention.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
[TBL] [Abstract][Full Text] [Related]
4. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
[TBL] [Abstract][Full Text] [Related]
5. The role of chemoprevention in cancer control.
Greenwald P; Kelloff GJ
IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
[TBL] [Abstract][Full Text] [Related]
6. An evidence-based approach to cancer prevention clinical trials.
Greenwald P; McDonald SS; Anderson DE
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S43-7. PubMed ID: 12570334
[TBL] [Abstract][Full Text] [Related]
7. Cancer chemoprevention: a summary of the current evidence.
Bonovas S; Tsantes A; Drosos T; Sitaras NM
Anticancer Res; 2008; 28(3B):1857-66. PubMed ID: 18630472
[TBL] [Abstract][Full Text] [Related]
8. G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials.
Hemstreet GP; Rao J; Hurst RE; Bonner RB; Waliszewski P; Grossman HB; Liebert M; Bane BL
J Cell Biochem Suppl; 1996; 25():197-204. PubMed ID: 9027619
[TBL] [Abstract][Full Text] [Related]
9. Surrogate endpoint biomarkers for phase II cancer chemoprevention trials.
Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet R; Doody LA
J Cell Biochem Suppl; 1994; 19():1-9. PubMed ID: 7823579
[TBL] [Abstract][Full Text] [Related]
10. Cancer chemoprevention.
Hong WK; Lippman SM
J Natl Cancer Inst Monogr; 1995; (17):49-53. PubMed ID: 8573453
[TBL] [Abstract][Full Text] [Related]
11. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention.
Niles RM
Acta Pharmacol Sin; 2007 Sep; 28(9):1383-91. PubMed ID: 17723172
[TBL] [Abstract][Full Text] [Related]
12. Micronutrients as chemopreventive agents.
Reddy BS
IARC Sci Publ; 1996; (139):221-35. PubMed ID: 8923033
[TBL] [Abstract][Full Text] [Related]
13. Prevention of prostate cancer through custom tailoring of chemopreventive regimen.
Siddiqui IA; Afaq F; Adhami VM; Mukhtar H
Chem Biol Interact; 2008 Jan; 171(2):122-32. PubMed ID: 17403520
[TBL] [Abstract][Full Text] [Related]
14. Data evaluation as a contribution to cancer prevention.
Stewart BW
IARC Sci Publ; 1996; (139):303-12. PubMed ID: 8923040
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention in lung carcinogenesis--an overview.
van Zandwijk N
Eur J Cancer; 2005 Sep; 41(13):1990-2002. PubMed ID: 16112567
[TBL] [Abstract][Full Text] [Related]
16. Point: Surrogate end point biomarkers are likely to be limited in their usefulness in the development of cancer chemoprevention agents against sporadic cancers.
Armstrong WB; Taylor TH; Meyskens FL
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):589-92. PubMed ID: 12869395
[No Abstract] [Full Text] [Related]
17. Mechanistic considerations in the evaluation of chemopreventive data.
Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet RA; Greenwald P; Hawk ET; Fay JR; Sigman CC
IARC Sci Publ; 1996; (139):203-19. PubMed ID: 8923032
[TBL] [Abstract][Full Text] [Related]
18. Cohorts with familial disposition for colon cancers in chemoprevention trials.
Burt RW
J Cell Biochem Suppl; 1996; 25():131-5. PubMed ID: 9027609
[TBL] [Abstract][Full Text] [Related]
19. [Chemoprevention of prostate cancer].
Xie LP; Qin J
Zhonghua Nan Ke Xue; 2005 Apr; 11(4):243-6. PubMed ID: 15921250
[TBL] [Abstract][Full Text] [Related]
20. Methods and strategies in lung cancer control.
Castonguay A
Cancer Res; 1992 May; 52(9 Suppl):2641s-2651s. PubMed ID: 1562994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
